- Home
- BEAT vs LNSR Comparison
BEAT vs LNSR Comparison
Compare BEAT & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- LNSR
- Stock Information
- Founded
- BEAT 2015
- LNSR 2004
- Country
- BEAT United States
- LNSR United States
- Employees
- BEAT N/A
- LNSR N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- LNSR Medical Electronics
- Sector
- BEAT Technology
- LNSR Health Care
- Exchange
- BEAT Nasdaq
- LNSR Nasdaq
- Market Cap
- BEAT 74.1M
- LNSR 63.4M
- IPO Year
- BEAT 2021
- LNSR N/A
- Fundamental
- Price
- BEAT $2.26
- LNSR $11.16
- Analyst Decision
- BEAT Buy
- LNSR
- Analyst Count
- BEAT 1
- LNSR 0
- Target Price
- BEAT $8.00
- LNSR N/A
- AVG Volume (30 Days)
- BEAT 110.4K
- LNSR 89.8K
- Earning Date
- BEAT 03-19-2025
- LNSR 03-03-2025
- Dividend Yield
- BEAT N/A
- LNSR N/A
- EPS Growth
- BEAT N/A
- LNSR N/A
- EPS
- BEAT N/A
- LNSR N/A
- Revenue
- BEAT N/A
- LNSR $48,868,000.00
- Revenue This Year
- BEAT N/A
- LNSR $25.07
- Revenue Next Year
- BEAT N/A
- LNSR $24.95
- P/E Ratio
- BEAT N/A
- LNSR N/A
- Revenue Growth
- BEAT N/A
- LNSR 21.29
- 52 Week Low
- BEAT $1.35
- LNSR $2.67
- 52 Week High
- BEAT $3.48
- LNSR $11.90
- Technical
- Relative Strength Index (RSI)
- BEAT 47.78
- LNSR 66.45
- Support Level
- BEAT $2.02
- LNSR $10.00
- Resistance Level
- BEAT $2.44
- LNSR $11.90
- Average True Range (ATR)
- BEAT 0.14
- LNSR 0.92
- MACD
- BEAT 0.04
- LNSR 0.20
- Stochastic Oscillator
- BEAT 50.00
- LNSR 73.15
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.